{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:25:33Z","timestamp":1782570333251,"version":"3.54.5"},"reference-count":53,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":354,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:p>Haemophilia A and B and von Willebrand disease account for 80\u201385% of all inherited bleeding disorders. The other 15% are represented by deficiencies of fibrinogen, prothrombin, or factors V, VII, X, XI, or XIII. In addition, acquired factor deficiencies are seen in a variety of conditions ranging from malignancies to autoimmune disorders. The spectrum of symptoms in these conditions varies from severe and life\u2010threatening haemorrhage to a mild bleeding diathesis. The diagnosis depends on demonstration of decreased activity of one of the clotting factors. Due to the rarity of each of the individual factor deficiencies, purified factor concentrates are not as readily available as they are for haemophilia A and B. Treatment of rare clotting factor deficiencies consists of the most purified blood product available that contains the missing factor. Depending on which factor is deficient, either purified concentrates, prothrombin complex concentrates, cryoprecipitate, or fresh frozen plasma can be used. In addition, recombinant factor VIIa is available for treating factor VII deficient patients.<\/jats:p>","DOI":"10.1046\/j.1365-2516.2001.00100.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T23:06:29Z","timestamp":1047423989000},"page":"16-22","source":"Crossref","is-referenced-by-count":57,"title":["Current therapy for rare factor deficiencies"],"prefix":"10.1111","volume":"7","author":[{"given":"J.","family":"Di Paola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830460416"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199709000-00011"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(85)90046-2"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1991.tb13464.x"},{"key":"e_1_2_9_6_2","unstructured":"KasperCK.Registry of clotting factor concentrates:http:\/\/www.wfh.org\/registry1.htm."},{"key":"e_1_2_9_7_2","unstructured":"RatnoffOD.Acquired disorders of hemostasis.In: Colman RW Hirsh J Marder VJ Salzman EW eds.Hemostasis and Thrombosis 3rd edn. Philadelphia J.B. Lipincott 1994:1107\u20138."},{"key":"e_1_2_9_8_2","first-page":"321.","article-title":"N\u00e9crose isch\u00e9mique bilat\u00e9rale dans un cas de grande hypofibrinog\u00e9n\u00e9mie cong\u00e9nitale.","volume":"4","author":"Caen J","year":"1964","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_9_9_2","first-page":"597.","article-title":"Congenital afibrinogenemia: vascular changes and multiple thrombosis induced by fibrinogen infusions and contraceptive medication.","volume":"140","author":"MacKinnon JJ","year":"1971","journal-title":"Can Med Assoc J"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000209109"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199810000-00001"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb07795.x"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1648968"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00362.x"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00620.x"},{"key":"e_1_2_9_16_2","first-page":"232","article-title":"Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is \u2018Pseudohomozyous\u2019 for activated protein C resistance.","volume":"77","author":"Guasch JF","year":"1997","journal-title":"Thromb Haemost"},{"key":"e_1_2_9_17_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ajcp\/97.1.84","article-title":"Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin.","volume":"97","author":"Rappaport SI","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199408000-00012"},{"key":"e_1_2_9_19_2","unstructured":"RobertsHR&LefkowitzJB.Inherited disorders of prothrombin conversion.In: Colman RW Hirsh J Marder VJ Salzman EW eds.Hemostasis and Thrombosis 3rd edn. Philadelphia J.B. Lipincott 1994:203\u20136."},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199705000-00009"},{"key":"e_1_2_9_21_2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood.V79.3.826.826","article-title":"Solvent\/detergent\u2010treated fresh frozen plasma: a virus\u2010inactivated substitute for fresh frozen plasma.","volume":"79","author":"Horowitz B","year":"1992","journal-title":"Blood"},{"key":"e_1_2_9_22_2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-0038-1642696","article-title":"Inherited factor VII deficiency: Genetics and molecular pathology.","volume":"74","author":"Tuddenham EGD","year":"1995","journal-title":"Thromb Haemost"},{"key":"e_1_2_9_23_2","unstructured":"RobertsHR&LefkowitzJB.Inherited disorders of prothrombin conversion.In: Colman RW Hirsh J Marder VJ Salzman EW eds.Hemostasis and Thrombosis 3rd edn. Philadelphia J.B. Lipincott 1994:206\u20138."},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198307000-00004"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830400108"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830500408"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00319.x"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1999.7730131.x"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00806.x"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198104023041407"},{"key":"e_1_2_9_31_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2257.1988.tb01176.x","article-title":"Factor X deficiency during treatment of relapsed acute myeloid leukemia with amsacrine.","volume":"10","author":"Carter C","year":"1998","journal-title":"Clin Lab Hematol"},{"key":"e_1_2_9_32_2","first-page":"572","article-title":"Transient acquired factor X deficiency associated with pneumonia.","volume":"84","author":"Currie MS","year":"1994","journal-title":"NY State J Med"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199205000-00012"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830460315"},{"key":"e_1_2_9_35_2","unstructured":"RobertsH&BinghamMD.Other Coagulation Factor Deficiencies In: Loscalzo J Schafer A eds.Thrombosis and Hemorrhage 2nd edn Baltimore Maryland: Williams & Wilkins 1998:773\u2013802."},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80618-7"},{"key":"e_1_2_9_37_2","first-page":"305","article-title":"Survival of transfused factor X in patients with Stuart disease.","volume":"18","author":"Roberts HR","year":"1965","journal-title":"Thrombosis Diathesis Haemorrhagica"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(96)80068-0"},{"key":"e_1_2_9_39_2","first-page":"314","article-title":"Definition of the bleeding tendency in factor XI deficient kindreds: a clinical and laboratory study.","volume":"67","author":"Bolton Maggs P","year":"1995","journal-title":"Thromb Haemost"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1646162"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107183250303"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1966.tb05617.x"},{"key":"e_1_2_9_43_2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0038-1648439","article-title":"Production and therapeutic use of a factor XI concentrate from plasma.","volume":"67","author":"Bolton Maggs P","year":"1992","journal-title":"Thromb Haemost"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92237-3"},{"key":"e_1_2_9_45_2","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1182\/blood.V84.4.1314.1314","article-title":"Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients.","volume":"84","author":"Mannucci PM","year":"1994","journal-title":"Blood"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2015.x"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199203040-00014"},{"key":"e_1_2_9_48_2","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1016\/S0021-9258(18)38136-5","article-title":"Immunoelectrophoretic characterization of the cross\u2010linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase.","volume":"266","author":"Shainoff JR","year":"1991","journal-title":"J Biol Chem"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb03979.x"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197911000-00002"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-198821000-00011"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00319641"},{"key":"e_1_2_9_53_2","first-page":"402","article-title":"A pasteurized concentrate of human plasma factor XIII for therapeutic use.","volume":"55","author":"Winkelman L","year":"1988","journal-title":"Thromb Hemost"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649787"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2516.2001.00100.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2516.2001.00100.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2516.2001.00100.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T07:59:25Z","timestamp":1695801565000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2516.2001.00100.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":53,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1046\/j.1365-2516.2001.00100.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2516.2001.00100.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}